CYP2C19 and gastroesophageal reflux disease: In conclusion, this study of 55 GERD patients who experienced omeprazole treatment failure showed a significant association with CYP2C19 ultrarapid phenotype inferred by CYP2C:TG/TG, but not CYP2C19*17/*17.